BMY logo

Bristol-Myers Squibb Company (BMY) Operating expenses

annual operating expenses:

$28.45B+$2.33B(+8.91%)
December 31, 2024

Summary

  • As of today (August 5, 2025), BMY annual total operating expenses is $28.45 billion, with the most recent change of +$2.33 billion (+8.91%) on December 31, 2024.
  • During the last 3 years, BMY annual operating expenses has risen by +$537.00 million (+1.92%).
  • BMY annual operating expenses is now -0.43% below its all-time high of $28.57 billion, reached on December 31, 2020.

Performance

1-year change

+8.91%

3-year change

+1.92%

5-year change

+134.04%

15-year change

+151.37%

BMY Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.18%
BMY annual total operating expenses is higher than 99.18% of companies in Healthcare sector

Range

All-time high

$28.57B
BMY annual total operating expenses is currently -0.43% below its historical high of $28.57 billion

3-year low

$26.12B
BMY annual total operating expenses is currently +8.91% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
BMY previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
BMY next annual earnings announcement has not yet been scheduled

OtherBMYincome statement metrics

Annual total expenses

$42.41B
BMY annual total expenses is $42.41 billion

annual interest expense

$1.95B
BMY annual interest expense is $1.95 billion

annual income tax

$554.00M
BMY annual income tax is $554.00 million

annual cost of goods sold

$13.97B
BMY annual cost of goods sold is $13.97 billion

quarterly operating expenses:

$5.12B+$452.00M(+9.68%)
June 30, 2025

Summary

  • As of today (August 5, 2025), BMY quarterly total operating expenses is $5.12 billion, with the most recent change of +$452.00 million (+9.68%) on June 30, 2025.
  • Over the past year, BMY quarterly operating expenses has dropped by -$2.12 billion (-29.27%).
  • BMY quarterly operating expenses is now -42.98% below its all-time high of $8.98 billion, reached on December 31, 2020.

Performance

3-month change

+9.68%

1-year change

-29.27%

3-year change

-21.49%

5-year change

-21.65%

BMY quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.97%
BMY quarterly total operating expenses is higher than 98.97% of companies in Healthcare sector

Range

All-time high

$8.98B
BMY quarterly total operating expenses is currently -42.98% below its historical high of $8.98 billion

3-year low

$4.67B
BMY quarterly total operating expenses is currently +9.68% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
BMY previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
BMY next earnings announcement is scheduled for Oct 30, 2025

OtherBMYincome statement metrics

Quarterly total expenses

$8.49B
BMY quarterly total expenses is $8.49 billion

quarterly interest expense

$485.00M
BMY quarterly interest expense is $485.00 million

quarterly income tax

$460.00M
BMY quarterly income tax is $460.00 million

quarterly cost of goods sold

$3.37B
BMY quarterly cost of goods sold is $3.37 billion

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

annual operating expenses

$28.45B
BMY annual total operating expenses is $28.45 billion

annual SGA

$8.41B
BMY annual SGA is $8.41 billion

annual D&A

$9.60B
BMY annual depreciation & amortization is $9.60 billion

BMY Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.9%-29.3%
3 y3 years+1.9%-21.5%
5 y5 years+134.0%-21.6%

BMY Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+8.9%-30.9%+9.7%
5 y5-year-0.4%+134.0%-43.0%+9.7%
alltimeall time-0.4%+620.1%-43.0%+1471.5%

BMY Operating expenses History

DateAnnualQuarterly
Jun 2025
-
$5.12B(+9.7%)
Mar 2025
-
$4.67B(-33.5%)
Dec 2024
$28.45B(+8.9%)
$7.02B(+3.8%)
Sep 2024
-
$6.76B(-6.6%)
Jun 2024
-
$7.24B(-2.4%)
Mar 2024
-
$7.42B(+8.6%)
Dec 2023
$26.12B(-3.0%)
$6.83B(+5.0%)
Sep 2023
-
$6.50B(+0.8%)
Jun 2023
-
$6.45B(+1.7%)
Mar 2023
-
$6.34B(-11.0%)
Dec 2022
$26.92B(-3.5%)
$7.12B(+5.2%)
Sep 2022
-
$6.77B(+3.7%)
Jun 2022
-
$6.53B(+0.3%)
Mar 2022
-
$6.51B(-10.7%)
Dec 2021
$27.91B(-2.3%)
$7.29B(-0.3%)
Sep 2021
-
$7.31B(+5.9%)
Jun 2021
-
$6.91B(+8.0%)
Mar 2021
-
$6.40B(-28.8%)
Dec 2020
$28.57B(+135.1%)
$8.98B(+34.2%)
Sep 2020
-
$6.70B(+2.4%)
Jun 2020
-
$6.54B(+3.2%)
Mar 2020
-
$6.34B(+29.7%)
Dec 2019
$12.15B(+10.7%)
$4.88B(+22.3%)
Sep 2019
-
$4.00B(+63.0%)
Jun 2019
-
$2.45B(+1.2%)
Mar 2019
-
$2.42B(-13.9%)
Dec 2018
$10.98B(-3.0%)
$2.81B(+18.5%)
Sep 2018
-
$2.37B(-33.1%)
Jun 2018
-
$3.55B(+59.8%)
Mar 2018
-
$2.22B(-34.1%)
Dec 2017
$11.32B(+13.3%)
$3.37B(+24.4%)
Sep 2017
-
$2.71B(-5.3%)
Jun 2017
-
$2.85B(+19.5%)
Mar 2017
-
$2.39B(-16.6%)
Dec 2016
$9.99B(-8.5%)
$2.86B(+24.4%)
Sep 2016
-
$2.30B(-9.0%)
Jun 2016
-
$2.53B(+13.6%)
Mar 2016
-
$2.23B(-35.8%)
Dec 2015
$10.92B(+6.7%)
$3.47B(+47.1%)
Sep 2015
-
$2.36B(-22.2%)
Jun 2015
-
$3.03B(+46.1%)
Mar 2015
-
$2.07B(-37.1%)
Dec 2014
$10.23B(+15.8%)
$3.29B(+48.9%)
Sep 2014
-
$2.21B(-14.9%)
Jun 2014
-
$2.60B(+22.0%)
Mar 2014
-
$2.13B(-7.6%)
Dec 2013
$8.84B(-2.7%)
$2.31B(+9.6%)
Sep 2013
-
$2.10B(-9.0%)
Jun 2013
-
$2.31B(+9.4%)
Mar 2013
-
$2.11B(-18.5%)
Dec 2012
$9.08B(+0.8%)
$2.59B(+18.2%)
Sep 2012
-
$2.19B(+0.1%)
Jun 2012
-
$2.19B(+4.0%)
Mar 2012
-
$2.10B(-16.4%)
Dec 2011
$9.01B(+9.1%)
$2.52B(+14.7%)
Sep 2011
-
$2.20B(-0.9%)
Jun 2011
-
$2.22B(+6.7%)
Mar 2011
-
$2.08B(-10.0%)
Dec 2010
$8.26B(+0.3%)
$2.31B(+18.6%)
Sep 2010
-
$1.95B(-1.6%)
Jun 2010
-
$1.98B(-2.1%)
Mar 2010
-
$2.02B(+2.1%)
Dec 2009
$8.23B(+11.6%)
$1.98B(-2.4%)
Sep 2009
-
$2.03B(-1.5%)
Jun 2009
-
$2.06B(-4.7%)
Mar 2009
-
$2.16B(+562.9%)
Dec 2008
$7.38B(-23.2%)
$326.00M(-86.4%)
Sep 2008
-
$2.40B(+6.9%)
Jun 2008
-
$2.25B(+0.6%)
Mar 2008
-
$2.23B(-26.8%)
Dec 2007
$9.60B
$3.05B(+36.0%)
Sep 2007
-
$2.25B(+1.5%)
DateAnnualQuarterly
Jun 2007
-
$2.21B(+0.9%)
Mar 2007
-
$2.19B(-6.5%)
Dec 2006
$9.13B(0.0%)
$2.34B(+5.1%)
Sep 2006
-
$2.23B(-1.8%)
Jun 2006
-
$2.27B(-0.4%)
Mar 2006
-
$2.28B(-4.5%)
Dec 2005
$9.13B(+2.3%)
$2.39B(+3.8%)
Sep 2005
-
$2.30B(+1.0%)
Jun 2005
-
$2.28B(+5.9%)
Mar 2005
-
$2.15B(-13.5%)
Dec 2004
$8.93B(+7.4%)
$2.49B(+16.5%)
Sep 2004
-
$2.14B(-1.5%)
Jun 2004
-
$2.17B(+2.2%)
Mar 2004
-
$2.13B(-9.6%)
Dec 2003
$8.31B(+11.3%)
$2.35B(+14.8%)
Sep 2003
-
$2.05B(+1.1%)
Jun 2003
-
$2.02B(+7.1%)
Mar 2003
-
$1.89B(-13.4%)
Dec 2002
$7.47B(+1.3%)
$2.18B(+20.7%)
Sep 2002
-
$1.81B(-0.1%)
Jun 2002
-
$1.81B(+8.1%)
Mar 2002
-
$1.67B(-21.0%)
Dec 2001
$7.38B(-1.3%)
$2.12B(+26.8%)
Sep 2001
-
$1.67B(-11.4%)
Jun 2001
-
$1.89B(+5.0%)
Mar 2001
-
$1.80B(+35.0%)
Dec 2000
$7.47B(-3.9%)
$1.33B(-34.3%)
Sep 2000
-
$2.02B(-21.5%)
Jun 2000
-
$2.58B(+31.0%)
Mar 2000
-
$1.97B(-9.4%)
Dec 1999
$7.78B(+6.0%)
$2.17B(+17.2%)
Sep 1999
-
$1.85B(-23.0%)
Jun 1999
-
$2.40B(+7.4%)
Mar 1999
-
$2.24B(+170.2%)
Dec 1998
$7.33B(-12.6%)
$829.00M(-61.3%)
Sep 1998
-
$2.14B(-2.9%)
Jun 1998
-
$2.21B(+2.3%)
Mar 1998
-
$2.16B(-8.9%)
Dec 1997
$8.39B(+9.4%)
$2.37B(+19.2%)
Sep 1997
-
$1.99B(-4.1%)
Jun 1997
-
$2.07B(+5.2%)
Mar 1997
-
$1.97B(-5.4%)
Dec 1996
$7.67B(+10.1%)
$2.08B(+15.0%)
Sep 1996
-
$1.81B(-6.5%)
Jun 1996
-
$1.93B(+4.9%)
Mar 1996
-
$1.84B(-8.4%)
Dec 1995
$6.96B(+16.7%)
$2.01B(+24.9%)
Sep 1995
-
$1.61B(-8.4%)
Jun 1995
-
$1.76B(+11.5%)
Mar 1995
-
$1.58B(-7.7%)
Dec 1994
$5.97B(-5.1%)
$1.71B(+23.9%)
Sep 1994
-
$1.38B(-10.2%)
Jun 1994
-
$1.54B(+14.5%)
Mar 1994
-
$1.34B(-38.1%)
Dec 1993
$6.29B(-5.2%)
$2.17B(+60.1%)
Sep 1993
-
$1.35B(-7.3%)
Jun 1993
-
$1.46B(+11.2%)
Mar 1993
-
$1.31B(-39.3%)
Dec 1992
$6.63B(+16.2%)
$2.16B(+39.6%)
Sep 1992
-
$1.55B(+0.8%)
Jun 1992
-
$1.53B(+10.1%)
Mar 1992
-
$1.39B(-15.4%)
Dec 1991
$5.71B(+8.1%)
$1.65B(+24.2%)
Sep 1991
-
$1.32B(-3.6%)
Jun 1991
-
$1.38B(+0.9%)
Mar 1991
-
$1.36B(-13.1%)
Dec 1990
$5.28B(-6.5%)
$1.57B(+25.8%)
Sep 1990
-
$1.25B(+0.3%)
Jun 1990
-
$1.24B(+1.4%)
Mar 1990
-
$1.23B
Dec 1989
$5.65B(+25.8%)
-
Dec 1988
$4.49B(+13.6%)
-
Dec 1987
$3.95B
-

FAQ

  • What is Bristol-Myers Squibb Company annual total operating expenses?
  • What is the all time high annual operating expenses for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual operating expenses year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly operating expenses year-on-year change?

What is Bristol-Myers Squibb Company annual total operating expenses?

The current annual operating expenses of BMY is $28.45B

What is the all time high annual operating expenses for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual total operating expenses is $28.57B

What is Bristol-Myers Squibb Company annual operating expenses year-on-year change?

Over the past year, BMY annual total operating expenses has changed by +$2.33B (+8.91%)

What is Bristol-Myers Squibb Company quarterly total operating expenses?

The current quarterly operating expenses of BMY is $5.12B

What is the all time high quarterly operating expenses for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly total operating expenses is $8.98B

What is Bristol-Myers Squibb Company quarterly operating expenses year-on-year change?

Over the past year, BMY quarterly total operating expenses has changed by -$2.12B (-29.27%)
On this page